Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Nighttime recordings of brain signals while changing deep brain stimulation in Parkinson's disease

Official title: Deep Brain Stimulation Neural Recordings of Varied Stimulation During Sleep in Parkinson's Disease - The DREAMS-PD Study

Run by The Cleveland Clinic · NCT07110376 · Data updated 2026-11-12

This project tests whether changing nighttime deep brain stimulation settings and recording brain signals during sleep can help understand and improve sleep in people with Parkinson's disease who have a Medtronic Percept PC implant.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment10 (estimated)
SponsorThe Cleveland Clinic
Academic / other
Locations1 site (Cleveland, Ohio)
StatusRecruiting
StartedNovember 22, 2025
Main results expectedDecember 31, 2026
Study endsMarch 31, 2027
Registry record updatedAugust 28, 2026
Trial IDNCT07110376 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults with idiopathic Parkinson's disease who have bilateral Medtronic Percept PC STN implants with stable, optimized settings for at least three months, can ambulate independently, and can provide informed consent.

Probably not a fit

Patients without the Percept PC device, those with other neurological diseases, untreated significant sleep apnea or active sleep disorders, major cognitive impairment, or who cannot travel to the study site are unlikely to benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This exploratory, prospective, single-center, naturalistic study uses a randomized crossover design to compare different nighttime DBS amplitude settings in people with Parkinson's disease who have bilateral Medtronic Percept PC STN implants. Participants undergo overnight recording of local field potentials (LFPs) and sleep measures while clinicians alternate stimulation amplitudes to capture electrophysiological signatures such as beta-band activity. The goal is to link changes in subcortical beta oscillations with sleep architecture and symptoms to identify biomarkers of the sleep state. Results will inform optimal stimulation parameters for sleep and the potential of LFP-guided adaptive (closed-loop) DBS.

Why it matters

Potential benefit: If successful, this work could identify stimulation settings or neural biomarkers that lead to better nighttime DBS strategies and improved sleep quality for people with Parkinson's.

How similar studies have gone: Prior DBS studies have demonstrated improvements in sleep and motor function, but applying LFP-guided or adaptive DBS specifically during sleep is a relatively novel approach that has not been tested in large trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Male or female \> 18 years of age
* Diagnosed with idiopathic Parkinson Disease
* Have bilateral implantation of Medtronic's PerceptTM PC (Medtronic Neurological Division, Minneapolis, MN, USA) Deep Brain Stimulation (DBS) system targeting the subthalamic nucleus (STN) and have had their stimulation settings optimized for a minimum of three months
* Report a response score of one or greater on question 1.7 of the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) part I;
* Demonstrate ability to ambulate independently;
* Be capable of providing informed consent;
* If taking sleep-supporting medications, dosing must be stable for at least 30 days

Exclusion Criteria:

* Presence of neurological diseases other than Parkinson Disease, such as stroke or multiple sclerosis
* Active sleep disorders, including narcolepsy, moderate to severe (Apnea-Hypopnea Index\>=15) untreated sleep apnea, uncontrolled restless legs syndrome
* Cognitive impairment meeting the criteria for dementia as per the Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (DSM-IV), based on formal neuropsychological evaluation
* Ongoing alcohol or substance abuse; Working night shifts or irregular work hours

The main concern for vulnerable subjects will be for the possibility of reduced decision-making capacity. For this we intend to exclude individuals who have a diagnosis of dementia.

Where it's running

  • Cleveland Clinic
    Cleveland, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.